180 related articles for article (PubMed ID: 23815339)
1. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical diagnostic and prognostic markers for melanoma.
Nosrati M; Kashani-Sabet M
Methods Mol Biol; 2014; 1102():259-73. PubMed ID: 24258983
[TBL] [Abstract][Full Text] [Related]
4. Melanoma molecular classes and prognosis in the postgenomic era.
Tremante E; Ginebri A; Lo Monaco E; Frascione P; Di Filippo F; Terrenato I; Benevolo M; Mottolese M; Pescarmona E; Visca P; Natali PG; Giacomini P
Lancet Oncol; 2012 May; 13(5):e205-11. PubMed ID: 22554548
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
6. Prognostic tissue markers in melanoma.
Moore DA; Pringle JH; Saldanha GS
Histopathology; 2012 Apr; 60(5):679-89. PubMed ID: 21880059
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
[TBL] [Abstract][Full Text] [Related]
8. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
10. New developments in biomarkers for melanoma.
Griewank KG; Ugurel S; Schadendorf D; Paschen A
Curr Opin Oncol; 2013 Mar; 25(2):145-51. PubMed ID: 23334230
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic techniques for primary cutaneous melanoma.
Lien MH; Sondak VK
G Ital Dermatol Venereol; 2009 Apr; 144(2):187-94. PubMed ID: 19357625
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
Wiesner T; Fried I; Cerroni L; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
[No Abstract] [Full Text] [Related]
13. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
14. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
15. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
16. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
[TBL] [Abstract][Full Text] [Related]
17. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
18. Systematic classification of melanoma cells by phenotype-specific gene expression mapping.
Widmer DS; Cheng PF; Eichhoff OM; Belloni BC; Zipser MC; Schlegel NC; Javelaud D; Mauviel A; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2012 May; 25(3):343-53. PubMed ID: 22336146
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
[TBL] [Abstract][Full Text] [Related]
20. Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.
Joyce CW; Murphy IG; Rafferty M; Ryan D; McDermott EW; Gallagher WM
Expert Rev Proteomics; 2012 Aug; 9(4):415-23. PubMed ID: 22967078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]